HCPCS Level II
J1555
Injection, immune globulin (cuvitru), 100 mg
Codes near J1555
These sit next to J1555 in the CMS Level II file. All J codes
- J1460Injection, gamma globulin, intramuscular, 1 cc
- J1551Injection, immune globulin (cutaquig), 100 mg
- J1552Injection, immune globulin (alyglo), 500 mg
- J1553Injection, immune globulin (yimmugo), 100 mg
- J1554Injection, immune globulin (asceniv), 500 mg
- J1556Injection, immune globulin (bivigam), 500 mg
- J1557Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1558Injection, immune globulin (xembify), 100 mg
- J1559Injection, immune globulin (hizentra), 100 mg
- J1560Injection, gamma globulin, intramuscular, over 10 cc
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00944-2850-01 | Cuvitru | Takeda Pharmaceuticals America, Inc. | 10 |
| 00944-2850-03 | Cuvitru | Takeda Pharmaceuticals America, Inc. | 20 |
| 00944-2850-05 | Cuvitru | Takeda Pharmaceuticals America, Inc. | 40 |
| 00944-2850-07 | Cuvitru | Takeda Pharmaceuticals America, Inc. | 80 |
| 00944-2850-09 | Cuvitru | Takeda Pharmaceuticals America, Inc. | 100 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.